{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:25:51Z","timestamp":1759638351277,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1124\/jpet.102.047860","type":"journal-article","created":{"date-parts":[[2003,4,19]],"date-time":"2003-04-19T03:13:41Z","timestamp":1050722021000},"page":"668-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["The Role of GABAB Receptors in the Discriminative Stimulus Effects of \u03b3-Hydroxybutyrate in Rats: Time Course and Antagonism Studies"],"prefix":"10.1016","volume":"305","author":[{"given":"Lawrence P.","family":"Carter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren R.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew W.","family":"Unzeitig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Coop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles P.","family":"France","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.047860_bib1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0028-3908(02)00026-6","article-title":"GABAB receptor-mediated increase of neurosteroids by \u03b3-hydroxybutyric acid.","volume":"42","author":"Barbaccia","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.102.047860_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050092","article-title":"Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB).","volume":"127","author":"Beardsley","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.102.047860_bib3","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0024-3205(82)90624-5","article-title":"High affinity binding sites for gamma-hydroxybutyric acid in rat brain.","volume":"30","author":"Benavides","year":"1982","journal-title":"Life Sci"},{"key":"10.1124\/jpet.102.047860_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0165-6147(99)01341-3","article-title":"Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential?","volume":"20","author":"Bernasconi","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.102.047860_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-2999(01)01334-6","article-title":"Role of GABAB receptors in the sedative\/hypnotic effect of \u03b3-hydroxybutyric acid.","volume":"428","author":"Carai","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.047860_bib6","first-page":"9","article-title":"Structure-activity relationship of GHB analogs at GHB and GABAA receptors in rat cerebral cortex.","volume":"812","author":"Carter","year":"2002","journal-title":"Neurosci Abstr"},{"key":"10.1124\/jpet.102.047860_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0031-9384(95)00086-X","article-title":"Blockade of the discriminative stimulus effects of \u03b3-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382.","volume":"58","author":"Colombo","year":"1995","journal-title":"Physiol Behav"},{"key":"10.1124\/jpet.102.047860_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0031-9384(98)00062-6","article-title":"Involvement of GABAA and GABAB receptors in the mediation of discriminative stimulus effects of \u03b3-hydroxybutyric acid.","volume":"64","author":"Colombo","year":"1998","journal-title":"Physiol Behav"},{"key":"10.1124\/jpet.102.047860_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00213-001-0951-8","article-title":"Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice.","volume":"160","author":"Cook","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.102.047860_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0022-3565(25)31400-X","article-title":"Identification of endogenous \u03b3-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain.","volume":"207","author":"Doherty","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.047860_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0006-2952(75)90130-6","article-title":"Metabolism of [1-14C]\u03b3-hydroxybutyric acid by rat brain after intraventricular injection.","volume":"24","author":"Doherty","year":"1975","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.047860_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-3565(24)29561-6","article-title":"Characterization of the discriminative stimulus effects of the neuroactive steroid pregnanolone.","volume":"297","author":"Engel","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.047860_bib13","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1021\/jm00017a015","article-title":"Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.","volume":"38","author":"Froestl","year":"1995","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.102.047860_bib14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1471-4159.1977.tb10670.x","article-title":"Kinetics of in vivo conversion of \u03b3-[3H]aminobutyric acid to \u03b3-[3H]hydroxybutyric acid by rat brain.","volume":"28","author":"Gold","year":"1977","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.102.047860_bib15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(24)36673-X","article-title":"\u03b3-hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide.","volume":"281","author":"Hechler","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.047860_bib16","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0028-3908(99)00131-8","article-title":"\u03b3-Hydroxybutyrate is a weak agonist at recombinant GABAB receptors.","volume":"38","author":"Lingenhoehl","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.102.047860_bib17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-3565(25)23017-8","article-title":"A specific \u03b3-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties.","volume":"255","author":"Maitre","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.047860_bib18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0091-3057(91)90061-6","article-title":"Pharmacological specificity of the phencyclidine discriminative stimulus in rats.","volume":"39","author":"Mansbach","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.102.047860_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0924-977X(97)00087-4","article-title":"Intravenous self-administration of gamma-hydroxybutyric acid in drug-na\u0131\u0308ve mice.","volume":"8","author":"Martellotta","year":"1998","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/jpet.102.047860_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050312","article-title":"Rewarding properties of \u03b3-hydroxybutyric acid: an evaluation through place preference paradigm.","volume":"132","author":"Martellotta","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.102.047860_bib21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1197\/aemj.9.7.730","article-title":"Gamma hydroxybutyric acid (GHB) intoxication.","volume":"9","author":"Mason","year":"2002","journal-title":"Acad Emerg Med"},{"key":"10.1124\/jpet.102.047860_bib22","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0006-2952(72)90301-2","article-title":"Conversion of 1, 4-butanediol to -hydroxybutyric acid in rat brain and in peripheral tissue.","volume":"21","author":"Maxwell","year":"1972","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.047860_bib23","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-3565(24)29240-5","article-title":"Binding characteristics of the \u03b3-hydroxybutyric acid receptor antagonist [3H](2 E)-(5-hydroxy-5,7,8,9-tetrahydro-6 H-benzo[a][7]annulen-6-ylidene ethanoic acid in the rat brain.","volume":"299","author":"Mehta","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.047860_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0091-3057(01)00579-2","article-title":"Discrimination of gamma-hydroxybutyrate an ethanol administered separately and as a mixture in rats.","volume":"70","author":"Metcalf","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.102.047860_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(00)00191-5","article-title":"GHB: a new and novel drug of abuse.","volume":"63","author":"Nicholson","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.102.047860_bib26","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/0006-2952(70)90087-0","article-title":"Formation and regional distribution of \u03b3-hydroxybutyric acid in mammalian brain.","volume":"19","author":"Roth","year":"1970","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.047860_bib27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0028-3908(66)90007-4","article-title":"\u03b3-Butyrolactone and \u03b3-hydroxybutyric acid. II. The pharmacologically active form.","volume":"5","author":"Roth","year":"1966","journal-title":"Int J Neuropharmacol"},{"key":"10.1124\/jpet.102.047860_bib28","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0006-2952(66)90045-1","article-title":"\u03b3-Butyrolactone and \u03b3-hydroxybutyric acid \u2013 I. Distribution and metabolism.","volume":"15","author":"Roth","year":"1966","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.047860_bib29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0006-2952(68)90010-5","article-title":"Evidence that central nervous system depression by 1,4-butanediol in mediated through a metabolite, gamma-hydroxybutyrate.","volume":"17","author":"Roth","year":"1968","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.047860_bib30","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/0006-2952(70)90086-9","article-title":"Mechanism of the \u03b3-hydroxybutyrate-induced increase in brain dopamine and its relationship to \u201csleep.\u201d","volume":"19","author":"Roth","year":"1970","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.047860_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(97)01503-3","article-title":"The anxiolytic effect of \u03b3-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.","volume":"342","author":"Schmidt-Mutter","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.047860_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02246035","article-title":"Failure of \u03b3-hydroxybutyrate to alter the function of the GABAA receptor complex in the rat cerebral cortex.","volume":"104","author":"Serra","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.102.047860_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-3565(25)30571-9","article-title":"Evaluation of the discriminative stimulus effects of morphine in the rat.","volume":"198","author":"Shannon","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.047860_bib34","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0006-2952(96)00477-7","article-title":"Relation of the [3H]\u03b3-hydroxybutyric acid (GHB) binding site to the \u03b3-aminobutyric acidB (GABAB) receptor in rat brain.","volume":"52","author":"Snead","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.047860_bib35","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/0006-2952(89)90645-X","article-title":"In vivo conversion of \u03b3-aminobutyric acid and 1,4-butanediol to \u03b3-hydroxybutyric acid in rat brain. Studies using stable isotopes.","volume":"38","author":"Snead","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.047860_bib36","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/0006-2952(84)90629-4","article-title":"\u03b3-Hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes.","volume":"33","author":"Snead","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.047860_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0028-3908(93)90163-W","article-title":"GABAA receptor function in the \u03b3-hydroxybutyrate model of generalized absence seizures.","volume":"32","author":"Snead","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.102.047860_bib38","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0022-3565(25)22507-1","article-title":"Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine.","volume":"270","author":"Terry","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.047860_bib39","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/BF00426468","article-title":"The stimulus properties of \u03b3-hydroxybutyrate.","volume":"73","author":"Winter","year":"1981","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.102.047860_bib40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0376-8716(98)00153-7","article-title":"Evaluation of the reinforcing and discriminative stimulus effects of \u03b3-hydroxybutyrate in rhesus monkeys.","volume":"54","author":"Woolverton","year":"1999","journal-title":"Drug Alcohol Depend"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524363323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524363323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.047860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:43:33Z","timestamp":1740008613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524363323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["S0022356524363323"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.047860","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2003,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of GABAB Receptors in the Discriminative Stimulus Effects of \u03b3-Hydroxybutyrate in Rats: Time Course and Antagonism Studies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.047860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}